Kenija -
angleščina -
Pharmacy and Poisons Board
alfantrine 80/480 tablets
pharmsmart ltd p.o. box 47689-00100, nairobi. - artemether in house and lumefantrine in house - tablet - each tablet contains:- artemether in house 80 mg… - artemether and lumefantrine
Kenija -
angleščina -
Pharmacy and Poisons Board
famoxiclav 625 film-coated tablet
pharmsmart ltd p.o. box 47689-00100 - amoxicillin trihydrate bp eqv. to amoxicillin and… - film-coated tablet - each film coated tablet contains: amoxicillin… - amoxicillin and enzyme inhibitor
Kenija -
angleščina -
Pharmacy and Poisons Board
furoxiclav 625mg tablets
pharmsmart ltd p.o. box 47689-00100, nairobi. - cefuroxime axetil equivalent to cefuroxime… - tablet - each tablet contains:- cefuroxime axetil usp 620… - other beta-lactam antibacterials
Kenija -
angleščina -
Pharmacy and Poisons Board
lovela plan-1 tablet
pharmsmart ltd p.o box 47689-00100, nairobi, kenya. - levonorgestrel bp - tablet - each uncoated tablet contains; levonorgestrel bp… - levonorgestrel
Avstralija -
angleščina -
APVMA (Australian Pesticides and Veterinary Medicines Authority)
tribute selective turf herbicide
2022 environmental science au pty ltd - foramsulfuron - oil-based suspension concentrates - foramsulfuron ungrouped active 22.5 g/l - herbicide - turf and lawn - see label for exclusions - crowsfoot grass | ryegrass | winter grass | annual blue grass | annual poa | crab grass | goose grass
Avstralija -
angleščina -
Department of Health (Therapeutic Goods Administration)
filter, apheresis
vantive pty ltd - 36194 - filter, apheresis - the prismaflex tpe 1000 and tpe 2000 set are indicated for use only with the prismaflex control unit or with the prismax control unit, after having selected the tpe therapy (therapeutic plasma exchange). the prismaflex tpe1000 and tpe2000 set is intended for use in therapeutic plasma exchange, thus in diseases where removal of plasma components is indicated. the use of the primsmaflex tpe 1000 set should be restricted to patients with a body weight greater than 9 kg (20lbs). the use of the prismaflex tpe 2000 set should be restricted to adults. the size, weight, state of uraemia, cardiac status and general physical condition of the patient must be evaluated by the prescribing physician before each treatment. the device should be used only on the direction of a physician who has evaluated all the pertinent features of this device in relation to the individual patient. patients with bleeding tendencies must be closely supervised during the treatment. the treatment should be discontinued if acute haemorrhage that can not be corrected (haematemesis, haemoptysis and melaena) occurs during tpe. all treatments administered via the prismaflex set must be prescribed by a physician.
Združene države Amerike -
angleščina -
NLM (National Library of Medicine)
duloxetine capsule delayed release
trigen laboratories, llc - duloxetine hydrochloride (unii: 9044sc542w) (duloxetine - unii:o5tnm5n07u) - duloxetine 20 mg